ArticleRegulatory toxicology and pharmacology : RTP2019

Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication.

P S Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.